Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Asymptomatic HIV”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Testing effectiveness (Phase 2)Study completedNCT00643643
What this trial is testing

Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

Who this might be right for
HIV Infections
ViiV Healthcare 41
Not applicableStudy completedNCT00001997
What this trial is testing

Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals

Who this might be right for
HIV Infections
Chiron Corporation
Not applicableStudy completedNCT01203332
What this trial is testing

Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young Adults

Who this might be right for
HIV
University of North Carolina, Chapel Hill 1,917
Not applicableStudy completedNCT00000707
What this trial is testing

Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT00841360
What this trial is testing

ID and Testing Via Friendship Networks

Who this might be right for
Asymptomatic HIVHIV Infections
University of North Carolina, Chapel Hill 535
Testing effectiveness (Phase 2)Study completedNCT00002357
What this trial is testing

The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms

Who this might be right for
HIV Infections
Hoechst Marion Roussel 144
Early research (Phase 1)Study completedNCT00001036
What this trial is testing

The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Not applicableStudy completedNCT01029548
What this trial is testing

Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult Subjects

Who this might be right for
HIV Infections
Barbara Ensoli, MD 73
Not applicableStudy completedNCT00002176
What this trial is testing

A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Not applicableStudy completedNCT00002260
What this trial is testing

An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

Who this might be right for
HIV Infections
Lederle Laboratories
Early research (Phase 1)Study completedNCT00917813
What this trial is testing

Anti-HIV Monoclonal Antibody KD-247

Who this might be right for
HIV Infections
The Chemo-Sero-Therapeutic Research Institute 27
Early research (Phase 1)Study completedNCT02456558
What this trial is testing

Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects

Who this might be right for
Asymptomatic HIV Infection
ApoPharma 30
Early research (Phase 1)Study completedNCT00000699
What this trial is testing

A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT00000667
What this trial is testing

A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT00973466
What this trial is testing

Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients

Who this might be right for
HIV InfectionsNeisseria GonorrhoeaeChlamydia Trachomatis+1 more
Insel Gruppe AG, University Hospital Bern 300
Early research (Phase 1)Study completedNCT00000977
What this trial is testing

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 52
Not applicableStudy completedNCT00001000
What this trial is testing

Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT00002373
What this trial is testing

The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Glaxo Wellcome 56
Testing effectiveness (Phase 2)UnknownNCT01067417
What this trial is testing

Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients

Who this might be right for
HIV Infections
Medical Research Council 83
Not applicableStudy completedNCT00002323
What this trial is testing

A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell

Who this might be right for
HIV Infections
Boehringer Ingelheim 60
Load More Results